TRHC
Income statement / Annual
Last year (2022), Tabula Rasa HealthCare, Inc.'s total revenue was $299.52 M,
a decrease of 9.58% from the previous year.
In 2022, Tabula Rasa HealthCare, Inc.'s net income was -$77.33 M.
See Tabula Rasa HealthCare, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$299.52 M
|
$331.26 M
|
$297.22 M
|
$284.71 M
|
$204.27 M
|
$134.55 M
|
$94.06 M
|
$70.04 M
|
$48.43 M
|
$25.14 M
|
| Cost of Revenue |
$232.60 M |
$233.36 M |
$204.81 M |
$181.36 M |
$137.67 M |
$93.66 M |
$65.18 M |
$49.13 M |
$37.81 M |
$20.92 M |
| Gross Profit |
$66.91 M |
$97.90 M |
$92.41 M |
$103.35 M |
$66.60 M |
$40.89 M |
$28.89 M |
$20.91 M |
$10.62 M |
$4.22 M |
| Gross Profit Ratio |
0.22 |
0.3 |
0.31 |
0.36 |
0.33 |
0.3 |
0.31 |
0.3 |
0.22 |
0.17 |
| Research and Development
Expenses |
$14.48 M
|
$19.79 M
|
$18.18 M
|
$21.74 M
|
$12.22 M
|
$5.63 M
|
$3.81 M
|
$2.88 M
|
$1.66 M
|
$1.34 M
|
| General & Administrative
Expenses |
$74.97 M
|
$73.76 M
|
$65.38 M
|
$50.90 M
|
$28.18 M
|
$21.18 M
|
$11.83 M
|
$7.12 M
|
$3.97 M
|
$2.48 M
|
| Selling & Marketing
Expenses |
$10.49 M
|
$25.97 M
|
$21.55 M
|
$25.27 M
|
$9.67 M
|
$5.54 M
|
$3.86 M
|
$2.88 M
|
$2.27 M
|
$1.78 M
|
| Selling, General &
Administrative Expenses |
$85.47 M
|
$99.73 M
|
$86.93 M
|
$76.17 M
|
$37.85 M
|
$26.72 M
|
$15.69 M
|
$10.00 M
|
$6.24 M
|
$4.26 M
|
| Other Expenses |
$23.35 M |
$47.71 M |
$45.04 M |
$34.28 M |
$16.80 M |
$0.00 |
$639,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$123.30 M |
$167.23 M |
$150.15 M |
$132.19 M |
$66.87 M |
$41.86 M |
$24.62 M |
$16.81 M |
$9.72 M |
$6.71 M |
| Cost And Expenses |
$355.90 M |
$400.58 M |
$354.96 M |
$313.54 M |
$204.54 M |
$135.52 M |
$89.79 M |
$65.93 M |
$47.53 M |
$27.63 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$9.03 M |
$9.11 M |
$20.74 M |
$15.99 M |
$906,000.00 |
$688,000.00 |
$4.49 M |
$5.92 M |
$1.35 M |
$833,000.00 |
| Depreciation &
Amortization |
$31.74 M
|
$47.71 M
|
$45.04 M
|
$34.28 M
|
$16.80 M
|
$9.51 M
|
$5.12 M
|
$3.93 M
|
$1.82 M
|
$1.12 M
|
| EBITDA |
-$24.64 M
|
-$21.62 M
|
-$20.35 M
|
$1.63 M
|
$16.53 M
|
$8.54 M
|
$3.89 M
|
$8.04 M
|
$2.71 M
|
-$1.76 M
|
| EBITDA Ratio |
-0.08 |
-0.07 |
-0.04 |
0.02 |
0.08 |
0.06 |
0.1 |
0.11 |
0.06 |
-0.05 |
| Operating Income Ratio
|
-0.19
|
-0.21
|
-0.19
|
-0.1
|
-0.24
|
0.04
|
0.05
|
0.09
|
0
|
-0.1
|
| Total Other
Income/Expenses Net |
-$20.56 M
|
-$9.11 M
|
-$20.74 M
|
-$15.99 M
|
-$906,000.00
|
-$688,000.00
|
-$10.26 M
|
-$6.64 M
|
-$2.41 M
|
-$1.38 M
|
| Income Before Tax |
-$76.95 M |
-$78.43 M |
-$86.13 M |
-$48.64 M |
-$50.65 M |
$4.51 M |
-$5.71 M |
-$2.54 M |
-$1.52 M |
-$3.87 M |
| Income Before Tax Ratio
|
-0.26
|
-0.24
|
-0.29
|
-0.17
|
-0.25
|
0.03
|
-0.06
|
-0.04
|
-0.03
|
-0.15
|
| Income Tax Expense |
$389,000.00 |
$627,000.00 |
-$5.17 M |
-$16.20 M |
-$3.38 M |
-$9.78 M |
$541,000.00 |
$328,000.00 |
-$409,000.00 |
$833,000.00 |
| Net Income |
-$77.33 M |
-$79.06 M |
-$80.97 M |
-$32.44 M |
-$47.27 M |
$14.30 M |
-$6.25 M |
-$2.86 M |
-$1.11 M |
-$3.87 M |
| Net Income Ratio |
-0.26 |
-0.24 |
-0.27 |
-0.11 |
-0.23 |
0.11 |
-0.07 |
-0.04 |
-0.02 |
-0.15 |
| EPS |
-3.18 |
-3.39 |
-3.71 |
-1.57 |
-2.48 |
0.76 |
-0.83 |
-0.29 |
-0.11 |
-0.39 |
| EPS Diluted |
-3.18 |
-3.39 |
-3.71 |
-1.57 |
-2.48 |
0.68 |
-0.54 |
-0.29 |
-0.11 |
-0.39 |
| Weighted Average Shares
Out |
$24.29 M
|
$23.29 M
|
$21.82 M
|
$20.62 M
|
$19.10 M
|
$16.73 M
|
$7.49 M
|
$9.86 M
|
$9.86 M
|
$9.86 M
|
| Weighted Average Shares
Out Diluted |
$24.29 M
|
$23.29 M
|
$21.82 M
|
$20.62 M
|
$19.10 M
|
$18.77 M
|
$11.59 M
|
$9.86 M
|
$9.86 M
|
$9.86 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
